510(k) K972094

TARGET CARDIAC TROPONIN I TEST by Texas Immunology, Inc. — Product Code MMI

K972094 is an FDA 510(k) premarket notification submitted by Texas Immunology, Inc. for the device "TARGET CARDIAC TROPONIN I TEST". The FDA issued a decision of Substantially Equivalent on July 23, 1997. The device falls under product code MMI (Immunoassay Method, Troponin Subunit), a Class II device regulated under 21 CFR 862.1215. Texas Immunology, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 23, 1997
Date Received
June 4, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Immunoassay Method, Troponin Subunit
Device Class
Class II
Regulation Number
862.1215
Review Panel
CH
Submission Type